RxDoctor Payments Data

John Dunham, MD

Family Medicine · Clarksville, ARNPI 1487624896

Payments from drug & device makers

$1,505in general payments, 2019–2025

Across 95 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$267
  • AbbVie$217
  • Pfizer$141
  • Amgen$121
  • AstraZeneca$120
  • Novo Nordisk$101
  • plus $537 from 16 others

What the payments were for

  • Food & beverage$1,505100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,505 in reported general payments places this provider in the 65th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$175,588
Medicare patients
322
Services billed
3,538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide103$115,168
Trelegy ElliptaFluticasone/Umeclidin/Vilanter116$79,887
OzempicSemaglutide63$68,047
EliquisApixaban106$62,309
JanuviaSitagliptin Phosphate62$52,668
FarxigaDapagliflozin Propanediol55$47,588
EntrestoSacubitril/Valsartan35$31,236
JardianceEmpagliflozin15$27,445
XareltoRivaroxaban46$26,259
MounjaroTirzepatide12$21,278
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen364$10,832
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$9,208
ArexvyRsvpref3 Antigen/As01e/Pf25$7,609
Victoza 2-PakLiraglutide11$6,102
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$5,885

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Arexvy, Shingrix$74$91,891161 claims
Novo NordiskOzempic$101$68,04763 claims
PfizerEliquis$141$62,309106 claims
AstraZenecaFarxiga, Breztri Aerosphere$120$56,79768 claims
MerckJanuvia$13$52,66862 claims
NovartisEntresto$11$31,23635 claims
Boehringer IngelheimJardiance$53$27,44515 claims
Johnson & JohnsonXarelto$12$26,25946 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Clarksville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →